347 related articles for article (PubMed ID: 16957197)
1. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model.
Daniel C; Poiret S; Goudercourt D; Dennin V; Leyer G; Pot B
Appl Environ Microbiol; 2006 Sep; 72(9):5799-805. PubMed ID: 16957197
[TBL] [Abstract][Full Text] [Related]
2. Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria.
Pavan S; Desreumaux P; Mercenier A
Clin Diagn Lab Immunol; 2003 Jul; 10(4):696-701. PubMed ID: 12853407
[TBL] [Abstract][Full Text] [Related]
3. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials.
Dunne C; Murphy L; Flynn S; O'Mahony L; O'Halloran S; Feeney M; Morrissey D; Thornton G; Fitzgerald G; Daly C; Kiely B; Quigley EM; O'Sullivan GC; Shanahan F; Collins JK
Antonie Van Leeuwenhoek; 1999; 76(1-4):279-92. PubMed ID: 10532384
[TBL] [Abstract][Full Text] [Related]
4. Probiotic properties of non-conventional lactic acid bacteria: immunomodulation by Oenococcus oeni.
Foligné B; Dewulf J; Breton J; Claisse O; Lonvaud-Funel A; Pot B
Int J Food Microbiol; 2010 Jun; 140(2-3):136-45. PubMed ID: 20452078
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide.
Macho Fernandez E; Valenti V; Rockel C; Hermann C; Pot B; Boneca IG; Grangette C
Gut; 2011 Aug; 60(8):1050-9. PubMed ID: 21471573
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of two probiotics in inflammatory bowel disease as observed in the trinitrobenzene sulfonic acid model of colitis.
Amit-Romach E; Uni Z; Reifen R
Dis Colon Rectum; 2008 Dec; 51(12):1828-36. PubMed ID: 18633675
[TBL] [Abstract][Full Text] [Related]
7. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes.
Roselli M; Finamore A; Nuccitelli S; Carnevali P; Brigidi P; Vitali B; Nobili F; Rami R; Garaguso I; Mengheri E
Inflamm Bowel Dis; 2009 Oct; 15(10):1526-36. PubMed ID: 19504616
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations.
Drouault-Holowacz S; Foligné B; Dennin V; Goudercourt D; Terpend K; Burckel A; Pot B
Clin Nutr; 2006 Dec; 25(6):994-1003. PubMed ID: 16698150
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics.
Mariman R; Kremer B; van Erk M; Lagerweij T; Koning F; Nagelkerken L
Inflamm Bowel Dis; 2012 Aug; 18(8):1424-33. PubMed ID: 22162025
[TBL] [Abstract][Full Text] [Related]
10. Probiotic and anti-inflammatory attributes of an isolate Lactobacillus helveticus NS8 from Mongolian fermented koumiss.
Rong J; Zheng H; Liu M; Hu X; Wang T; Zhang X; Jin F; Wang L
BMC Microbiol; 2015 Oct; 15():196. PubMed ID: 26428623
[TBL] [Abstract][Full Text] [Related]
11. Klebsiella pneumoniae increases the risk of inflammation and colitis in a murine model of intestinal bowel disease.
Lee IA; Kim DH
Scand J Gastroenterol; 2011 Jun; 46(6):684-93. PubMed ID: 21410316
[TBL] [Abstract][Full Text] [Related]
12. New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches.
Alard J; Peucelle V; Boutillier D; Breton J; Kuylle S; Pot B; Holowacz S; Grangette C
Benef Microbes; 2018 Feb; 9(2):317-331. PubMed ID: 29488412
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effect of soymilk fermented by a riboflavin-producing Lactobacillus plantarum strain in a murine model of colitis.
Levit R; de Giori GS; de Moreno de LeBlanc A; LeBlanc JG
Benef Microbes; 2017 Feb; 8(1):65-72. PubMed ID: 27873546
[TBL] [Abstract][Full Text] [Related]
14. Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects.
Foligné B; Nutten S; Steidler L; Dennin V; Goudercourt D; Mercenier A; Pot B
Dig Dis Sci; 2006 Feb; 51(2):390-400. PubMed ID: 16534687
[TBL] [Abstract][Full Text] [Related]
15. Colonic responses to Lactobacillus farciminis treatment in trinitrobenzene sulphonic acid-induced colitis in rats.
Lamine F; Eutamène H; Fioramonti J; Buéno L; Théodorou V
Scand J Gastroenterol; 2004 Dec; 39(12):1250-8. PubMed ID: 15743003
[TBL] [Abstract][Full Text] [Related]
16. Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice.
Lee HS; Han SY; Bae EA; Huh CS; Ahn YT; Lee JH; Kim DH
Int Immunopharmacol; 2008 Apr; 8(4):574-80. PubMed ID: 18328449
[TBL] [Abstract][Full Text] [Related]
17. Isolation of adhesive strains and evaluation of the colonization and immune response by Lactobacillus plantarum L2 in the rat gastrointestinal tract.
Wang B; Li J; Li Q; Zhang H; Li N
Int J Food Microbiol; 2009 Jun; 132(1):59-66. PubMed ID: 19386375
[TBL] [Abstract][Full Text] [Related]
18. Probiotic properties of Lactobacillus strains isolated from the feces of breast-fed infants and Taiwanese pickled cabbage.
Wang CY; Lin PR; Ng CC; Shyu YT
Anaerobe; 2010 Dec; 16(6):578-85. PubMed ID: 20951815
[TBL] [Abstract][Full Text] [Related]
19. Effect of a probiotic Lactobacillus plantarum TN8 strain on trinitrobenzene sulphonic acid-induced colitis in rats.
Trabelsi I; Ktari N; Ben Slima S; Hamden K; Ben Salah R
J Anim Physiol Anim Nutr (Berl); 2017 Apr; 101(2):311-319. PubMed ID: 27435031
[TBL] [Abstract][Full Text] [Related]
20. Effects of exopolysaccharide-producing probiotic strains on experimental colitis in rats.
Sengül N; Aslím B; Uçar G; Yücel N; Işik S; Bozkurt H; Sakaoğullari Z; Atalay F
Dis Colon Rectum; 2006 Feb; 49(2):250-8. PubMed ID: 16362802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
